OBJECTIVES:
To investigate the effect of furosemide on the time to confirmation for ureteral patency during routine cystoscopy.
MATERIALS AND METHODS:
We conducted a double-blind randomized placebo-controlled trial investigating the effect of furosemide on the time to confirmation for ureteral patency during routine cystoscopy.
Inclusion criteria included women who underwent a cystoscopy as part of their urogynecologic surgical procedure within the Division of Female Pelvic Medicine and Reconstructive Surgery (FPMRS) at the University of South Florida (USF) from May 2017 to March 2018. Patients were randomized to either the active drug (furosemide 10 mg; 1 cc) or placebo (normal saline; 1 cc) group at the time of cystoscopy using an allocation ratio of one to one using block randomization, with blocks of four and stratified by age (<65 and 65). Primary outcome was time to confirmation of bilateral ureteral patency recorded in seconds. Secondary outcomes included adverse reaction to study medication, delayed diagnosis of ureteric injury, and change in postoperative renal function as measured by creatinine. Wilcoxon-Mann-Whitney test was used for continuous variables and c2 test for categorical variables. Kaplan-Meier survival curves were used to describe the pattern of ureteral patency confirmation along with a cox proportional-hazards regression to calculate crude hazard ratios (HRs). RESULTS: The administration of furosemide 10mg in a routine cystoscopy resulted in a significantly shorter time to confirmation compared to the administration of the placebo (86.5 seconds, IQR: 55.0-137.0 vs. 165.0 seconds, IQR 77.0-280.0; p <0.05). Furthermore, at any given time period, patients receiving furosemide 10mg were 2.3 times more likely to have ureteral patency confirmed compared with patients receiving normal saline (95% CI: 1.59 e 3.23). There were no adverse events related to administration of furosemide and no postoperative complications, including no delayed diagnosis of ureteric injury. CONCLUSION: This randomized controlled trial demonstrates that the routine use of furosemide intraoperatively decreases the time to confirm ureteral patency in patients undergoing urogynecologic procedures.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:
Simon Patton: Nothing to disclose; Jean P. Tanner: Nothing to disclose; Isabel C. Prieto: Nothing to disclose; Elisha Jackson: Nothing to disclose; Kristie A. Greene: Nothing to disclose; Renee Bassaly: Nothing to disclose; Allison M. Wyman: Nothing to disclose. 
MATERIALS AND METHODS:
Our study is a prospective, non-blinded, randomized control trial conducted at Banner-University Medical Center Phoenix (Phoenix, Arizona). Each participant was randomized to either the Pink PadÒ system (Group 1) or the traditional egg-crate foam (Group 2) in the preoperative area. After induction of anesthesia, initial measurements of anatomic landmarks were obtained at the left iliac crest, left shoulder acromion process, and most caudal aspect of the left buttocks with a two provider verification. The surgery was performed as routine by the gynecologic surgeon with the total duration of time in Trendelenburg position documented. At the completion of the surgery, and prior to reversal of anesthesia, the measurements were repeated at the anatomic landmarks with the bed in a neutral position. Any shift in position, measured as the distance from the original marks to the new marks based on patient's current position, was recorded.
RESULTS: Fifty subjects met inclusion criteria and were included in the analysis; ten subjects were excluded for various protocol deviations. Group 1 contained 24 patients and Group 2 contained 26 patients. The mean cephalad migration in centimeters of Group 1 versus Group 2 was 4.8 vs 4.3 (p¼0.56), 4.6 vs 3.9 (p¼0.39), 3.5 vs 2.6 (p¼0.20) at the left iliac crest, left shoulder, and left buttock respectively; none of the migrations were significantly different however there was a trend towards less migration with Group 2. Duration of time in Trendelenburg position was not correlated with migration at any of the measured locations (mean 121.8 minutes, Pearson correlation coefficient 0.16, 0.13, 0.17 at iliac crest, shoulder, buttock respectively). BMI was also not correlated with migration at any of the measured locations (mean BMI 35.8, range 19-65, Pearson correlation coefficient 0.30, 0.15, 0.12 at iliac crest, shoulder, buttock respectively). CONCLUSION: Our study shows that the Pink PadÒ system did not result in decreased cephalad migration in Trendelenburg position during robotic gynecologic surgery and has a trend towards inferiority. We therefore conclude that during robotic gynecologic surgery the egg-crate foam is an acceptable option with at least equal efficacy and has less associated equipment costs.
